Private Equity

Updated:

HBM Partners

HBM Partners was established in 2001. It operates as a private equity manager with a narrow focus on healthcare. The firm pursues buyouts, growth equity,...

HBM Partners logo

HBM Partners

HBM Partners was established in 2001. It operates as a private equity manager with a narrow focus on healthcare. The firm pursues buyouts, growth equity, early-stage venture, and PIPE transactions. Asset classes include biotechnology, medical devices, pharmaceuticals, and healthcare IT. Activity spans Switzerland and other European markets. No public confirmation exists on team size or additional offices. The firm advises HBM Healthcare Investments AG and other vehicles. No distinct structural features beyond its healthcare specialization appear in available records.

General information

Firm type

Private Equity

Year founded

2001

AUM

Undisclosed

Location

Region

Europe

Country

Switzerland

City

Zug

Corporate office

Bundesplatz 1, CH-6300 Zug, Switzerland

Sector focus

HealthcareBiotechnologyPharmaceuticals

Frequently asked questions

What asset classes does HBM Partners target?

The firm allocates across private equity buyouts, growth equity, early-stage venture, and public investments in healthcare companies.

Which sectors receive the majority of capital?

Capital concentrates in biotechnology, pharmaceuticals, medical devices, and healthcare IT.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Zug Private Equity profiles